Scientists have developed two new drugs to both prevent the COVID-19 infection, and also treat people who have been exposed to the novel coronavirus so that they do not develop severe disease. The peptide-based drugs developed by researchers at QIMR Berghofer Medical Research Institute in Australia
Drugs have been developed by QIMR Berghofer Medical Research Institute. Researchers have detailed findings in a study published in Nature Cell Discovery on 24 May.